KLOXXADO is a Nasal Spray in the Human Prescription Drug category. It is labeled and distributed by Hikma Specialty Usa Inc.. The primary component is Naloxone Hydrochloride.
Product ID | 59467-679_323cf7b3-8ee2-4018-8762-80605b57f6dc |
NDC | 59467-679 |
Product Type | Human Prescription Drug |
Proprietary Name | KLOXXADO |
Generic Name | Naloxone Hcl |
Dosage Form | Spray |
Route of Administration | NASAL |
Marketing Start Date | 2021-08-03 |
Marketing Category | NDA / |
Application Number | NDA212045 |
Labeler Name | Hikma Specialty USA Inc. |
Substance Name | NALOXONE HYDROCHLORIDE |
Active Ingredient Strength | 8 mg/.1mL |
Pharm Classes | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-08-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KLOXXADO 88751046 not registered Live/Pending |
Hikma Pharmaceuticals USA Inc. 2020-01-08 |